CYTOF News — Page 2
Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.
| Date | Type | Publisher | Headline | Summary |
|---|---|---|---|---|
| 2019-01-17 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2018-12-21 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2018-12-13 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2018-12-11 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2018-11-30 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2018-11-29 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2018-11-27 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2018-11-15 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2018-10-17 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2018-08-15 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2018-08-03 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2018-07-17 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2018-07-13 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2018-06-28 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2018-06-15 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2018-06-07 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2018-05-15 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2018-05-02 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2018-03-22 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2018-03-13 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2018-02-09 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2018-01-30 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2018-01-29 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2018-01-16 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2018-01-04 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2017-11-28 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2017-10-16 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2017-10-11 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2017-09-28 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2017-09-26 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2017-08-24 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2017-08-10 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2017-05-11 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2017-04-13 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2017-03-31 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2017-03-14 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2017-02-21 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2017-02-14 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2017-02-03 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2016-12-06 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2016-11-10 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2016-10-11 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2016-09-19 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2016-08-18 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2016-07-19 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2016-06-01 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2016-05-11 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2016-04-11 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2016-04-08 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2016-03-14 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2015-11-12 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2015-08-19 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2015-05-28 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2015-05-20 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2015-05-04 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2015-05-04 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2015-04-24 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2015-03-30 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2015-03-19 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2015-02-11 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2014-12-03 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2014-09-15 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |